secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2025-12-01T23:59:59+00:00
Accession:  0001493152-25-025469
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaPro subsidiary reports $740K loss; going concern doubt flagged by auditor
-----------------------------------------------------------------------------

- BriaPro net loss $740,216 for year ended July 31, 2025, accumulated deficit $1,180,425.
- Auditor's report includes material uncertainty about BriaPro's ability to continue as a going concern.
- BriaPro has $1 cash, $1.15M current liabilities, and total assets of $184,526 primarily intangible assets.
- Subsidiary wholly dependent on BriaCell for financing; no commercial operations yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225025469/0001493152-25-025469-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225025469/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025469

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer